HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia

Journal of Cellular Physiology

Volumn 229, Issue 10, 2014, Pages 1511-1520

  Shan, Fabo ^a,b,c   Li, Junxia ^c   Huang, Qing Yuan ^a,b,c  

^a Key Laboratory of High Altitude Medicine   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACTILE PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN G; MICRORNA; MICRORNA 106B; MICRORNA 143; MICRORNA 145; MICRORNA 25; MICRORNA 9; MICRORNA 93; MYOCARDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; DELETION MUTANT; DNA BINDING MOTIF; EPIGENETICS; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENE SWITCHING; GENETIC TRANSFECTION; HYPOXIC CELL; IMMUNOPRECIPITATION; LUNG ALVEOLUS CELL; MODULATION; NONHUMAN; PHENOTYPE; PHENOTYPIC MODULATION; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN MOTIF; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; RAT; SMOOTH MUSCLE FIBER; TRANSIENT TRANSFECTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BINDING SITES; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PULMONARY ARTERY; RATS; RNA INTERFERENCE; TIME FACTORS; TRANSCRIPTION INITIATION SITE; TRANSFECTION; UP-REGULATION;

EID: 84902314338     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24593     Document Type: Article

References (46)

1. Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V, Ward JP. 2006. Hypoxic pulmonary vasoconstriction: Mechanisms and controversies. J Physiol 570:53-58.
2. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. 2010. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 30:1118-1126.
3. Alexander MR, Owens GK. 2012. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 74:13-40.
4. Barman SA, Zhu S, White RE. 2004. Protein kinase C inhibits BKCa channel activity in pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 286:L149-L155.
5. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
6. Cai X, Hagedorn CH, Cullen BR. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957-1966.
7. Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI. 2012. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 14:868-879.
8. Charron CE, Chou PC, Coutts DJ, Kumar V, To M, Akashi K, Pinhu L, Griffiths M, Adcock IM, Barnes PJ, Ito K. 2009. Hypoxia-inducible factor 1alpha induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription. J Biol Chem 284:36047-36054.
9. Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H, Jiang X, Arnovitz S, Xu M, Hong GM, Elkahloun AG, Neilly MB, Wunderlich M, Larson RA, Le Beau MM, Mulloy JC, Liu PP, Rowley JD, Chen J. 2013. MiR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA 110:11511-11516.
10. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. 2009. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105:158-166.
11. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. 2009. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705-710.
12. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. 2003. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 23:2425-2437.
13. Feng S, Cong S, Zhang X, Bao X, Wang W, Li H, Wang Z, Wang G, Xu J, Du B, Qu D, Xiong W, Yin M, Ren X, Wang F, He J, Zhang B. 2011. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 39:6669-6678.
14. Fu Y, Zhang Y, Wang Z, Wang L, Wei X, Zhang B, Wen Z, Fang H, Pang Q, Yi F. 2010. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am J Nephrol 32:581-589.
15. Jeffery TK, Morrell NW. 2002. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45:173-202.
16. Jie W, Guo J, Shen Z, Wang X, Zheng S, Wang G, Ao Q. 2010. Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells. Exp Mol Pathol 89:301-306.
17. Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, Caffarelli E. 2010. A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res 38:6895-6905.
18. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
19. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlethwaite PA. 2009. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15:1289-1297.
20. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. 2009. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104:476-487.
21. Long X, Bell RD, Gerthoffer WT, Zlokovic BV, Miano JM. 2008. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler Thromb Vasc Biol 28:1505-1510.
22. Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, He ML, Kung H, Li XP. 2014. MiR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis doi: 10.1093/carcin/bgt354 [Epub ahead of print].
23. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. 2010. MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12:247-256.
24. Maltepe E, Krampitz GW, Okazaki KM, Red-Horse K, Mak W, Simon MC, Fisher SJ. 2005. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development 132:3393-3403.
25. Marsboom G, Archer SL. 2008. Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells. Circ Res 103:1047-1049.
26. McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. 2012. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 93:594-604.
27. Owens GK, Kumar MS, Wamhoff BR. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767-801.
28. Parmacek MS. 2008. Myocardin: dominant driver of the smooth muscle cell contractile phenotype. Arterioscler Thromb Vasc Biol 28:1416-1417.
29. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y. 2011. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129:2611-2620.
30. Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP, Meister G. 2011. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J 30:4309-4322.
31. Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C. 2012. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 287:29516-29528.
32. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, Sylvester JT. 2001. Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 281:L202-L208.
33. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL. 2006. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 291:L941-L949.
34. Stenmark KR, Fagan KA, Frid MG. 2006. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99:675-691.
35. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C. 2011. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109:880-893.
36. Wang GL, Semenza GL. 1993. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304-4308.
37. 2+ in pulmonary arterial smooth muscle cells. Circ Res 98:1528-1537.
38. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428:185-189.
39. Wang K, Long B, Zhou J, Li PF. 2010. MiR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem 285:11903-11912.
40. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL. 2009. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 106:4260-4265.
41. Yang L, Chao J, Kook YH, Gao Y, Yao H, Buch SJ. 2013. Involvement of miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell Death Dis 4:e960.
42. Yi B, Cui J, Ning JN, Wang GS, Qian GS, Lu KZ. 2012. Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling. Gene 492:354-360.
43. Yildiz P. 2009. Molecular mechanisms of pulmonary hypertension. Clin Chim Acta 403:9-16.
44. Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. 2011. MicroRNA-9: Functional evolution of a conserved small regulatory RNA. RNA Biol 8:557-564.
45. Zhou W, Dasgupta C, Negash S, Raj JU. 2007. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: Role of cGMP-dependent protein kinase. Am J Physiol Lung Cell Mol Physiol 292:L1459-L1466.
46. Zhou W, Negash S, Liu J, Raj JU. 2009. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: Role of cGMP-dependent protein kinase and myocardin. Am J Physiol Lung Cell Mol Physiol 296:L780-L789.